{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T17:03:17Z","timestamp":1790528597332,"version":"4.1.0"},"reference-count":187,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["418453"],"award-info":[{"award-number":["418453"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomaterials"],"abstract":"<jats:p>According to the global cancer observatory (GLOBOCAN), there are approximately 18 million new cancer cases per year worldwide. Cancer therapies are largely limited to surgery, radiotherapy, and chemotherapy. In radiotherapy and chemotherapy, the maximum tolerated dose is presently being used to treat cancer patients. The integrated development of innovative nanoparticle (NP) based approaches will be a key to address one of the main issues in both radiotherapy and chemotherapy: normal tissue toxicity. Among other inorganic NP systems, gold nanoparticle (GNP) based systems offer the means to further improve chemotherapy through controlled delivery of chemotherapeutics, while local radiotherapy dose can be enhanced by targeting the GNPs to the tumor. There have been over 20 nanotechnology-based therapeutic products approved for clinical use in the past two decades. Hence, the goal of this review is to understand what we have achieved so far and what else we can do to accelerate clinical use of GNP-based therapeutic platforms to minimize normal tissue toxicity while increasing the efficacy of the treatment. Nanomedicine will revolutionize future cancer treatment options and our ultimate goal should be to develop treatments that have minimum side effects, for improving the quality of life of all cancer patients.<\/jats:p>","DOI":"10.3390\/nano10091671","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T09:05:37Z","timestamp":1598432737000},"page":"1671","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Advances in Gold Nanoparticle-Based Combined Cancer Therapy"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-7365","authenticated-orcid":false,"given":"Kyle","family":"Bromma","sequence":"first","affiliation":[{"name":"Department of Physics and Astronomy, University of Victoria, Victoria, BC V8P 5C2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5251-1388","authenticated-orcid":false,"given":"Devika B.","family":"Chithrani","sequence":"additional","affiliation":[{"name":"Department of Physics and Astronomy, University of Victoria, Victoria, BC V8P 5C2, Canada"},{"name":"British Columbia Cancer, Medical Physics, Victoria, BC V8R 6V5, Canada"},{"name":"Centre for Advanced Materials and Related Technologies (CAMTEC), University of Victoria, Victoria, BC V8P 5C2, Canada"},{"name":"Centre for Biomedical Research, University of Victoria, Victoria, BC V8P 5C2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ruddon, R.W. (2007). Cancer Biology, Oxford University Press. [4th ed.].","DOI":"10.1093\/oso\/9780195175448.001.0001"},{"key":"ref_2","unstructured":"(2020, August 06). Treatment-Canadian Cancer Society. Available online: https:\/\/www.cancer.ca\/en\/cancer-information\/diagnosis-and-treatment\/treatment\/?region=on."},{"key":"ref_3","unstructured":"(2020, August 06). Types of Cancer Treatment-National Cancer Institute, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/types."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Joiner, M.C., and van der Kogel, A.J. (2018). Basic Clinical Radiobiology, CRC Press. [5th ed.].","DOI":"10.1201\/9780429490606"},{"key":"ref_5","unstructured":"Podgorsak, E.B. (2003). Radiation Oncology Physics: A Handbook for Teachers and Students, International Atomic Energy Agency."},{"key":"ref_6","unstructured":"Podgor\u0161ak, E.B. (2016). Radiation Physics for Medical Physicists, Springer International Publishing."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Delaney, G.P., and Barton, M.B. (2015). Evidence-based Estimates of the Demand for Radiotherapy. Clin. Oncol.","DOI":"10.1016\/j.clon.2014.10.005"},{"key":"ref_8","first-page":"11","article-title":"Principles of chemoradiation: Theoretical and practical considerations","volume":"13","author":"Herscher","year":"1999","journal-title":"Oncology"},{"key":"ref_9","unstructured":"Tannock, I.F., Hill, R.P., Bristow, R.G., and Harrington, L. (2005). Basic Science of Oncology, McGraw-Hill Education. [5th ed.]."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Crawford, S. (2013). Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy. Front. Pharmacol., 68.","DOI":"10.3389\/fphar.2013.00068"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bioeng.1.1.241","article-title":"Transport of molecules, particles, and cells in solid tumors","volume":"1","author":"Jain","year":"1999","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8897","DOI":"10.1002\/anie.201003316","article-title":"Nanoparticle-Mediated Delivery of Bleomycin","volume":"49","author":"Georgelin","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrc2394","article-title":"Paul Ehrlich\u2019s magic bullet concept: 100 Years of progress","volume":"8","author":"Strebhardt","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: An emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-3-319-16555-4_13","article-title":"Cancer nanotherapeutics in clinical trials","volume":"166","author":"Kauffman","year":"2015","journal-title":"Cancer Treat. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in Medicine: Therapeutic Applications and Developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7150\/thno.11642","article-title":"Nanoparticles for radiation therapy enhancement: The key parameters","volume":"5","author":"Retif","year":"2015","journal-title":"Theranostics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.1021\/ja034830z","article-title":"On the interactions of free radicals with gold nanoparticles","volume":"125","author":"Zhang","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1166\/rnn.2013.1022","article-title":"Low Energy Electrons in Nanoscale Radiation Physics: Relationship to Radiosensitization and Chemoradiation Therapy","volume":"2","author":"Zheng","year":"2013","journal-title":"Rev. Nanosci. Nanotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1039\/c2nr30769c","article-title":"In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles","volume":"4","author":"Townley","year":"2012","journal-title":"Nanoscale"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2013.04.004","article-title":"The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: A proof-of-concept","volume":"108","author":"Mirjolet","year":"2013","journal-title":"Radiother. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12030-008-9009-x","article-title":"Analysis of potential radiosensitizing materials for x-ray-induced photodynamic therapy","volume":"3","author":"Takahashi","year":"2007","journal-title":"Nanobiotechnology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ijrobp.2008.06.1916","article-title":"Semiconductor Nanoparticles as Energy Mediators for Photosensitizer-Enhanced Radiotherapy","volume":"72","author":"Yang","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Chithrani, D.B., Jelveh, S., Jalali, F., Van Prooijen, M., Allen, C., Bristow, R.G., Hill, R.P., and Jaffray, D.A. (2010). Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat. Res.","DOI":"10.1667\/RR1984.1"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9566","DOI":"10.1021\/nn202797h","article-title":"Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles","volume":"5","author":"Miladi","year":"2011","journal-title":"ACS Nano"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11829","DOI":"10.1039\/c3nr01351k","article-title":"Silver nanoparticles: A novel radiation sensitizer for glioma?","volume":"5","author":"Liu","year":"2013","journal-title":"Nanoscale"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1211\/jpp.60.8.0005","article-title":"Radiotherapy enhancement with gold nanoparticles","volume":"60","author":"Hainfeld","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Hainfeld, J.F., Slatkin, D.N., and Smilowitz, H.M. (2004). The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol.","DOI":"10.1088\/0031-9155\/49\/18\/N03"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zheng, Y., and Sanche, L. (2009). Gold nanoparticles enhance DNA damage induced by anti-cancer drugs and radiation. Radiat. Res.","DOI":"10.1667\/RR1689.1"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1039\/C1NR11188D","article-title":"Gold nanoparticles: Preparation, properties, and applications in bionanotechnology","volume":"4","author":"Yeh","year":"2012","journal-title":"Nanoscale"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Stiufiuc, R., Iacovita, C., Nicoara, R., Stiufiuc, G., Florea, A., Achim, M., and Lucaciu, C.M. (2013). One-step synthesis of PEGylated gold nanoparticles with tunable surface charge. J. Nanomater.","DOI":"10.1155\/2013\/146031"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.molpharmaceut.8b00810","article-title":"Gold Nanoparticles in Cancer Treatment","volume":"16","author":"Sztandera","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Huff, T.B., Tong, L., Zhao, Y., Hansen, M.N., Cheng, J.X., and Wei, A. (2007). Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine.","DOI":"10.2217\/17435889.2.1.125"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Rastinehad, A.R., Anastos, H., Wajswol, E., Winoker, J.S., Sfakianos, J.P., Doppalapudi, S.K., Carrick, M.R., Knauer, C.J., Taouli, B., and Lewis, S.C. (2019). Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proc. Natl. Acad. Sci. USA.","DOI":"10.1073\/pnas.1906929116"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Vines, J.B., Yoon, J.H., Ryu, N.E., Lim, D.J., and Park, H. (2019). Gold nanoparticles for photothermal cancer therapy. Front. Chem., 7.","DOI":"10.3389\/fchem.2019.00167"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1021\/acs.jpcc.5b11232","article-title":"Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles","volume":"120","author":"Abadeer","year":"2016","journal-title":"J. Phys. Chem. C"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mendes, R., Pedrosa, P., Lima, J.C., Fernandes, A.R., and Baptista, P.V. (2017). Photothermal enhancement of chemotherapy in breast cancer by visible irradiation of Gold Nanoparticles. Sci. Rep.","DOI":"10.1038\/s41598-017-11491-8"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ash, C., Dubec, M., Donne, K., and Bashford, T. (2017). Effect of wavelength and beam width on penetration in light-tissue interaction using computational methods. Lasers Med. Sci.","DOI":"10.1007\/s10103-017-2317-4"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17967","DOI":"10.1039\/C9NR04301B","article-title":"Recent advances in ultra-small fluorescent Au nanoclusters toward oncological research","volume":"11","author":"Yang","year":"2019","journal-title":"Nanoscale"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1039\/C9TB02767J","article-title":"Gold nanoclusters for biomedical applications: Toward: In vivo studies","volume":"8","author":"Porret","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1021\/acs.bioconjchem.9b00669","article-title":"Recent Advances in Molecular Imaging with Gold Nanoparticles","volume":"31","author":"Hsu","year":"2020","journal-title":"Bioconjug. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Loynachan, C.N., Soleimany, A.P., Dudani, J.S., Lin, Y., Najer, A., Bekdemir, A., Chen, Q., Bhatia, S.N., and Stevens, M.M. (2019). Renal clearable catalytic gold nanoclusters for in vivo disease monitoring. Nat. Nanotechnol.","DOI":"10.1038\/s41565-019-0527-6"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Bromma, K., Rieck, K., Kulkarni, J., O\u2019Sullivan, C., Sung, W., Cullis, P., Schuemann, J., and Chithrani, D.B. (2019). Use of a lipid nanoparticle system as a Trojan horse in delivery of gold nanoparticles to human breast cancer cells for improved outcomes in radiation therapy. Cancer Nanotechnol.","DOI":"10.1186\/s12645-019-0046-z"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Mathiyazhakan, M., Wiraja, C., and Xu, C. (2018). A Concise Review of Gold Nanoparticles-Based Photo-Responsive Liposomes for Controlled Drug Delivery. Nano-Micro Lett.","DOI":"10.1007\/s40820-017-0166-0"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Chithrani, D.B. (2011). Optimization of Bio-Nano Interface Using Gold Nanostructures as a Model Nanoparticle System. Insci. J.","DOI":"10.5640\/insc.0103115"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Libutti, S.K., Paciotti, G.F., Byrnes, A.A., Alexander, H.R., Gannon, W.E., Walker, M., Seidel, G.D., Yuldasheva, N., and Tamarkin, L. (2010). Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res.","DOI":"10.1158\/1078-0432.CCR-10-0978"},{"key":"ref_48","unstructured":"(2010). Clinicaltrials Pilot Study of AuroLase(tm) Therapy in Refractory and\/or Recurrent Tumors of the Head and Neck."},{"key":"ref_49","unstructured":"Nanospectra Biosciences Inc (2016). Efficacy Study of AuroLase Therapy in Subjects with Primary and\/or Metastatic Lung Tumors."},{"key":"ref_50","unstructured":"Nanospectra Biosciences Inc (2016). MRI\/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue."},{"key":"ref_51","unstructured":"Northwesten Universty (2019). NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Schuemann, J., Bagley, A., Berbeco, R., Bromma, K., Butterworth, K.T., Byrne, H., Chithrani, D.B., Cho, S.H., Cook, J.R., and Favaudon, V. (2020). Roadmap for metal nanoparticles in radiation therapy: Current status, translational challenges, and future directions. Phys. Med. Biol.","DOI":"10.1088\/1361-6560\/ab9159"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Rubin, P., and Carter, S.K. (1976). Combination Radiation Therapy and Chemotherapy: A Logical Basis for Their Clinical Use. CA. Cancer J. Clin.","DOI":"10.3322\/canjclin.26.5.274"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2019.08.032","article-title":"Plasmonic gold nanoparticles: Optical manipulation, imaging, drug delivery and therapy","volume":"311","author":"Sharifi","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Dykman, L.A., and Khlebtsov, N.G. (2019). Gold nanoparticles in chemo-, immuno-, and combined therapy: Review [Invited]. Biomed. Opt. Express.","DOI":"10.1364\/BOE.10.003152"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2019.02.025","article-title":"Gold nanoparticles in combinatorial cancer therapy strategies","volume":"387","author":"Beik","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.talanta.2018.02.088","article-title":"Recent biomedical applications of gold nanoparticles: A review","volume":"184","author":"Elahi","year":"2018","journal-title":"Talanta"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e1449","DOI":"10.1002\/wnan.1449","article-title":"Gold nanoparticle-mediated photothermal therapy: Applications and opportunities for multimodal cancer treatment","volume":"9","author":"Riley","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Siddique, S., and Chow, J.C.L. (2020). Gold nanoparticles for drug delivery and cancer therapy. Appl. Sci., 10.","DOI":"10.3390\/app10113824"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.addr.2015.12.012","article-title":"Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements","volume":"109","author":"Her","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kong, F.Y., Zhang, J.W., Li, R.F., Wang, Z.X., Wang, W.J., and Wang, W. (2017). Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications. Molecules, 22.","DOI":"10.3390\/molecules22091445"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMra1608986","article-title":"Recent developments in radiotherapy","volume":"377","author":"Citrin","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Foroozandeh, P., and Aziz, A.A. (2018). Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles. Nanoscale Res. Lett., 13.","DOI":"10.1186\/s11671-018-2728-6"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Chithrani, B.D., Stewart, J., Allen, C., and Jaffray, D.A. (2009). Intracellular uptake, transport, and processing of nanostructures in cancer cells. Nanomed. Nanotechnol. Biol. Med.","DOI":"10.1016\/j.nano.2009.01.008"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/09687688.2010.507787","article-title":"Intracellular uptake, transport, and processing of gold nanostructures","volume":"27","author":"Chithrani","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Chithrani, B.D., Ghazani, A.A., and Chan, W.C.W. (2006). Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett.","DOI":"10.1021\/nl052396o"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Gao, H., Shi, W., and Freund, L.B. (2005). Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA.","DOI":"10.1073\/pnas.0503879102"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Jin, H., Heller, D.A., Sharma, R., and Strano, M.S. (2009). Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: Single particle tracking and a generic uptake model for nanoparticles. ACS Nano.","DOI":"10.1021\/nn800532m"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Jin, H., Heller, D.A., and Strano, M.S. (2008). Single-particle tracking of endocytosis and exocytosis of single-walled carbon nanotubes in NIH-3T3 cells. Nano Lett.","DOI":"10.1021\/nl072969s"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Ma, X., Wu, Y., Jin, S., Tian, Y., Zhang, X., Zhao, Y., Yu, L., and Liang, X.J. (2011). Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano.","DOI":"10.1021\/nn202155y"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Liu, M., Li, Q., Liang, L., Li, J., Wang, K., Li, J., Lv, M., Chen, N., Song, H., and Lee, J. (2017). Real-Time visualization of clustering and intracellular transport of gold nanoparticles by correlative imaging. Nat. Commun.","DOI":"10.1038\/ncomms15646"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Chithrani, B.D., and Chan, W.C.W. (2007). Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett.","DOI":"10.1021\/nl070363y"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Bednarski, M., Dudek, M., Knutelska, J., Nowi\u0144ski, L., Sapa, J., Zygmunt, M., Nowak, G., Luty-B\u0142ocho, M., Wojnicki, M., and Fitzner, K. (2015). The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies. Pharmacol. Rep.","DOI":"10.1016\/j.pharep.2014.10.019"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Zhang, X.D., Wu, H.Y., Wu, D., Wang, Y.Y., Chang, J.H., Zhai, Z.B., Meng, A.M., Liu, P.X., Zhang, L.A., and Fan, F.Y. (2010). Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomed.","DOI":"10.2147\/IJN.S8428"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/nnm.10.23","article-title":"Editorial: Understanding and overcoming major barriers in cancer nanomedicine","volume":"5","author":"Nie","year":"2010","journal-title":"Nanomedicine"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Cruje, C., Yang, C., Uertz, J., Van Prooijen, M., and Chithrani, B.D. (2015). Optimization of PEG coated nanoscale gold particles for enhanced radiation therapy. RSC Adv.","DOI":"10.1039\/C5RA19104A"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Cruje, C., and Chithrani, D.B. (2014). Polyethylene Glycol Functionalized Nanoparticles for Improved Cancer Treatment. Rev. Nanosci. Nanotechnol.","DOI":"10.1166\/rnn.2014.1042"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., and Reinhardt, C. (2013). Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat. Nanotechnol.","DOI":"10.1038\/nnano.2013.181"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Carnovale, C., Bryant, G., Shukla, R., and Bansal, V. (2017). Gold nanoparticle biodistribution and toxicity: Role of biological corona in relation with nanoparticle characteristics. Metal Nanoparticles in Pharma, Springer International Publishing.","DOI":"10.1007\/978-3-319-63790-7_18"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Yang, C., Bromma, K., and Chithrani, D. (2018). Peptide mediated in vivo tumor targeting of nanoparticles through optimization in single and multilayer in vitro cell models. Cancers (Basel), 10.","DOI":"10.3390\/cancers10030084"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Manson, J., Kumar, D., Meenan, B.J., and Dixon, D. (2011). Polyethylene glycol functionalized gold nanoparticles: The influence of capping density on stability in various media. Gold Bull.","DOI":"10.1007\/s13404-011-0023-8"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zhang, G., Yang, Z., Lu, W., Zhang, R., Huang, Q., Tian, M., Li, L., Liang, D., and Li, C. (2009). Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials.","DOI":"10.1016\/j.biomaterials.2008.12.038"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Chess","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Yin, H.Q., Bi, F.L., and Gan, F. (2015). Rapid synthesis of cyclic RGD conjugated gold nanoclusters for targeting and fluorescence imaging of melanoma A375 cells. Bioconjug. Chem.","DOI":"10.1021\/bc500505c"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Rieck, K., Bromma, K., Sung, W., Bannister, A., Schuemann, J., and Chithrani, D.B. (2019). Modulation of gold nanoparticle mediated radiation dose enhancement through synchronization of breast tumor cell population. Br. J. Radiol., 92.","DOI":"10.1259\/bjr.20190283"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Cho, W.S., Cho, M., Jeong, J., Choi, M., Han, B.S., Shin, H.S., Hong, J., Chung, B.H., Jeong, J., and Cho, M.H. (2010). Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol.","DOI":"10.1016\/j.taap.2010.02.013"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Li, X., Hu, Z., Ma, J., Wang, X., Zhang, Y., Wang, W., and Yuan, Z. (2018). The systematic evaluation of size-dependent toxicity and multi-time biodistribution of gold nanoparticles. Colloids Surf. B Biointerfaces.","DOI":"10.1016\/j.colsurfb.2018.04.005"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"494","DOI":"10.7150\/thno.42471","article-title":"Ultrasmall gold nanoparticles in cancer diagnosis and therapy","volume":"10","author":"Fan","year":"2020","journal-title":"Theranostics"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Bugno, J., Poellmann, M.J., Sokolowski, K., Hsu, H.J., Kim, D.H., and Hong, S. (2019). Tumor penetration of Sub-10 nm nanoparticles: Effect of dendrimer properties on their penetration in multicellular tumor spheroids. Nanomed. Nanotechnol. Biol. Med.","DOI":"10.1016\/j.nano.2019.102059"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Kharazian, B., Lohse, S.E., Ghasemi, F., Raoufi, M., Saei, A.A., Hashemi, F., Farvadi, F., Alimohamadi, R., Jalali, S.A., and Shokrgozar, M.A. (2018). Bare surface of gold nanoparticle induces inflammation through unfolding of plasma fibrinogen. Sci. Rep.","DOI":"10.1038\/s41598-018-30915-7"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Elci, S.G., Jiang, Y., Yan, B., Kim, S.T., Saha, K., Moyano, D.F., Yesilbag Tonga, G., Jackson, L.C., Rotello, V.M., and Vachet, R.W. (2016). Surface Charge Controls the Suborgan Biodistributions of Gold Nanoparticles. ACS Nano.","DOI":"10.1021\/acsnano.6b02086"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Riviere, J.E., Jaberi-Douraki, M., Lillich, J., Azizi, T., Joo, H., Choi, K., Thakkar, R., and Monteiro-Riviere, N.A. (2018). Modeling gold nanoparticle biodistribution after arterial infusion into perfused tissue: Effects of surface coating, size and protein corona. Nanotoxicology.","DOI":"10.1080\/17435390.2018.1476986"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Geng, F., Xing, J.Z., Chen, J., Yang, R., Hao, Y., Song, K., and Kong, B. (2014). Pegylated glucose gold nanoparticles for improved in-vivo bio-distribution and enhanced radiotherapy on cervical cancer. J. Biomed. Nanotechnol.","DOI":"10.1166\/jbn.2014.1855"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1358\/dot.2005.41.2.882662","article-title":"Cetuximab: An epidermal growth factor receptor chimeric human-murine monoclonal antibody","volume":"41","author":"Harding","year":"2005","journal-title":"Drugs Today"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Kao, H.W., Lin, Y.Y., Chen, C.C., Chi, K.H., Tien, D.C., Hsia, C.C., Lin, W.J., Chen, F.D., Lin, M.H., and Wang, H.E. (2014). Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model. Nanotechnology.","DOI":"10.1088\/0957-4484\/25\/29\/295102"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Ni, X., Castanares, M., Mukherjee, A., and Lupold, S.E. (2011). Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons. Curr. Med. Chem.","DOI":"10.2174\/092986711797189600"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Jo, H., and Ban, C. (2016). Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools. Exp. Mol. Med., 5.","DOI":"10.1038\/emm.2016.44"},{"key":"ref_99","first-page":"1617","article-title":"Active targeting schemes for nanoparticle systems in cancer therapeutics","volume":"15","author":"Byrne","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Choi, C.H.J., Alabi, C.A., Webster, P., and Davis, M.E. (2010). Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc. Natl. Acad. Sci. USA.","DOI":"10.1073\/pnas.0914140107"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1016\/j.bmc.2010.06.045","article-title":"Conjugating folic acid to gold nanoparticles through glutathione for targeting and detecting cancer cells","volume":"18","author":"Zhang","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jconrel.2018.01.002","article-title":"Gold nanoparticle should understand protein corona for being a clinical nanomaterial","volume":"272","author":"Charbgoo","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"de Carvalho, T.G., Garcia, V.B., de Ara\u00fajo, A.A., da Silva Gasparotto, L.H., Silva, H., Guerra, G.C.B., de Castro Miguel, E., de Carvalho Leit\u00e3o, R.F., da Silva Costa, D.V., and Cruz, L.J. (2018). Spherical neutral gold nanoparticles improve anti-inflammatory response, oxidative stress and fibrosis in alcohol-methamphetamine-induced liver injury in rats. Int. J. Pharm.","DOI":"10.1016\/j.ijpharm.2018.06.008"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"10644","DOI":"10.1021\/la0513712","article-title":"Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview","volume":"23","author":"Shukla","year":"2005","journal-title":"Langmuir"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Connor, E.E., Mwamuka, J., Gole, A., Murphy, C.J., and Wyatt, M.D. (2005). Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small.","DOI":"10.1002\/smll.200400093"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Steckiewicz, K.P., Barcinska, E., Malankowska, A., Zauszkiewicz\u2013Pawlak, A., Nowaczyk, G., Zaleska-Medynska, A., and Inkielewicz-Stepniak, I. (2019). Impact of gold nanoparticles shape on their cytotoxicity against human osteoblast and osteosarcoma in in vitro model. Evaluation of the safety of use and anti-cancer potential. J. Mater. Sci. Mater. Med.","DOI":"10.1007\/s10856-019-6221-2"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Zhang, X.D., Wu, D., Shen, X., Chen, J., Sun, Y.M., Liu, P.X., and Liang, X.J. (2012). Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials.","DOI":"10.1016\/j.biomaterials.2012.05.047"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Fratoddi, I., Venditti, I., Cametti, C., and Russo, M.V. (2015). How toxic are gold nanoparticles? The state-of-the-art. Nano Res.","DOI":"10.1007\/s12274-014-0697-3"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Jia, Y.P., Ma, B.Y., Wei, X.W., and Qian, Z.Y. (2017). The in vitro and in vivo toxicity of gold nanoparticles. Chin. Chem. Lett.","DOI":"10.1016\/j.cclet.2017.01.021"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Haume, K., Rosa, S., Grellet, S., \u015amia\u0142ek, M.A., Butterworth, K.T., Solov\u2019yov, A.V., Prise, K.M., Golding, J., and Mason, N.J. (2016). Gold nanoparticles for cancer radiotherapy: A review. Cancer Nanotechnol., 7.","DOI":"10.1186\/s12645-016-0021-x"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Nath, R., Bongiorni, P., and Rockwell, S. (1990). Iododeoxyuridine radiosensitization by low- and high-energy photons for brachytherapy dose rates. Radiat. Res.","DOI":"10.2307\/3577836"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Matsudaira, H., Ueno, A.M., and Furuno, I. (1980). Iodine contrast medium sensitizes cultured mammalian cells to X rays but not to \u03b3 rays. Radiat. Res.","DOI":"10.2307\/3575225"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Xie, W.Z., Friedland, W., Li, W.B., Li, C.Y., Oeh, U., Qiu, R., Li, J.L., and Hoeschen, C. (2015). Simulation on the molecular radiosensitization effect of gold nanoparticles in cells irradiated by x-rays. Phys. Med. Biol.","DOI":"10.1088\/0031-9155\/60\/16\/6195"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Khoo, A.M., Cho, S.H., Reynoso, F.J., Aliru, M., Aziz, K., Bodd, M., Yang, X., Ahmed, M.F., Yasar, S., and Manohar, N. (2017). Radiosensitization of Prostate Cancers in Vitro and in Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold Nanoparticles. Sci. Rep.","DOI":"10.1038\/s41598-017-18304-y"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Yang, C., Bromma, K., Di Ciano-Oliveira, C., Zafarana, G., van Prooijen, M., and Chithrani, D.B. (2018). Gold nanoparticle mediated combined cancer therapy. Cancer Nanotechnol.","DOI":"10.1117\/12.2295461"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Yang, C., Bromma, K., Sung, W., Schuemann, J., and Chithrani, D. (2018). Determining the radiation enhancement effects of gold nanoparticles in cells in a combined treatment with cisplatin and radiation at therapeutic megavoltage energies. Cancers (Basel), 10.","DOI":"10.3390\/cancers10050150"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Wolfe, T., Chatterjee, D., Lee, J., Grant, J.D., Bhattarai, S., Tailor, R., Goodrich, G., Nicolucci, P., and Krishnan, S. (2015). Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo. Nanomed. Nanotechnol. Biol. Med.","DOI":"10.1016\/j.nano.2014.12.016"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Rosa, S., Connolly, C., Schettino, G., Butterworth, K.T., and Prise, K.M. (2017). Biological mechanisms of gold nanoparticle radiosensitization. Cancer Nanotechnol., 8.","DOI":"10.1186\/s12645-017-0026-0"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1039\/C2CY20068F","article-title":"Catalytic activity of unsupported gold nanoparticles","volume":"3","author":"Mikami","year":"2013","journal-title":"Catal. Sci. Technol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1114397","article-title":"Toxic potential of materials at the nanolevel","volume":"311","author":"Nel","year":"2006","journal-title":"Science"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Misawa, M., and Takahashi, J. (2011). Generation of reactive oxygen species induced by gold nanoparticles under x-ray and UV Irradiations. Nanomed. Nanotechnol. Biol. Med.","DOI":"10.1016\/j.nano.2011.01.014"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Butterworth, K.T., McMahon, S.J., Currell, F.J., and Prise, K.M. (2012). Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale.","DOI":"10.1039\/c2nr31227a"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Pan, Y., Leifert, A., Ruau, D., Neuss, S., Bornemann, J., Schmid, G., Brandau, W., Simon, U., and Jahnen-Dechent, W. (2009). Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small.","DOI":"10.1002\/smll.200900466"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Pawlik, T.M., and Keyomarsi, K. (2004). Role of cell cycle in mediating sensitivity to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.","DOI":"10.1016\/j.ijrobp.2004.03.005"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Butterworth, K.T., Coulter, J.A., Jain, S., Forker, J., McMahon, S.J., Schettino, G., Prise, K.M., Currell, F.J., and Hirst, D.G. (2010). Evaluation of cytotoxicity and radiation enhancement using 1.9nm gold particles: Potential application for cancer therapy. Nanotechnology.","DOI":"10.1088\/0957-4484\/21\/29\/295101"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Elbayoumi, T.A. (2010). Nano drug-delivery systems in cancer therapy: Gains, pitfalls and considerations in DMPK and PD. Ther. Deliv., 1.","DOI":"10.4155\/tde.10.31"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ddr.20066","article-title":"Colloidal gold nanoparticles: A novel nanoparticle platform for developing multifunctional tumor-targeted drug delivery vectors","volume":"67","author":"Paciotti","year":"2006","journal-title":"Drug Dev. Res."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Paciotti, G.F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R.E., and Tamarkin, L. (2004). Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. J. Deliv. Target. Ther. Agents.","DOI":"10.1080\/10717540490433895"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Ghosh, P., Han, G., De, M., Kim, C.K., and Rotello, V.M. (2008). Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev., 60.","DOI":"10.1016\/j.addr.2008.03.016"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fchem.2016.00008","article-title":"Surface Analysis of Gold Nanoparticles Functionalized with Thiol-Modified Glucose SAMs for Biosensor Applications","volume":"4","author":"Spampinato","year":"2016","journal-title":"Front. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.sbsr.2016.04.002","article-title":"Various methods of gold nanoparticles (GNPs) conjugation to antibodies","volume":"9","author":"Jazayeri","year":"2016","journal-title":"Sens. Bio-Sens. Res."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Awotunde, O., Okyem, S., Chikoti, R., and Driskell, J.D. (2020). The Role of Free Thiol on Protein Adsorption to Gold Nanoparticles. Langmuir.","DOI":"10.1021\/acs.langmuir.0c01550"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Paciotti, G.F., Zhao, J., Cao, S., Brodie, P.J., Tamarkin, L., Huhta, M., Myer, L.D., Friedman, J., and Kingston, D.G.I. (2016). Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery. Bioconjug. Chem.","DOI":"10.1021\/acs.bioconjchem.6b00405"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"7702","DOI":"10.1021\/acs.chemrev.8b00253","article-title":"Achieving Controlled Biomolecule-Biomaterial Conjugation","volume":"118","author":"Spicer","year":"2018","journal-title":"Chem. Rev."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Brown, S.D., Nativo, P., Smith, J.A., Stirling, D., Edwards, P.R., Venugopal, B., Flint, D.J., Plumb, J.A., Graham, D., and Wheate, N.J. (2010). Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J. Am. Chem. Soc.","DOI":"10.1021\/ja908117a"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1039\/C4TB00383G","article-title":"Gold nanoparticles and gold nanoparticle-conjugates for delivery of therapeutic molecules. Progress and challenges","volume":"2","author":"Fratoddi","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Patra, C.R., Bhattacharya, R., Wang, E., Katarya, A., Lau, J.S., Dutta, S., Muders, M., Wang, S., Buhrow, S.A., and Safgren, S.L. (2008). Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res.","DOI":"10.1158\/0008-5472.CAN-07-6102"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Du, Y., Xia, L., Jo, A., Davis, R.M., Bissel, P., Ehrich, M.F., and Kingston, D.G.I. (2018). Synthesis and Evaluation of Doxorubicin-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery. Bioconjug. Chem.","DOI":"10.1021\/acs.bioconjchem.7b00756"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Fran\u00e7ois, A., Laroche, A., Pinaud, N., Salmon, L., Ruiz, J., Robert, J., and Astruc, D. (2011). Encapsulation of docetaxel into PEGylated gold nanoparticles for vectorization to cancer cells. ChemMedChem.","DOI":"10.1002\/cmdc.201100311"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Farooq, M.U., Novosad, V., Rozhkova, E.A., Wali, H., Ali, A., Fateh, A.A., Neogi, P.B., Neogi, A., and Wang, Z. (2018). Gold Nanoparticles-enabled Efficient Dual Delivery of Anticancer Therapeutics to HeLa Cells. Sci. Rep.","DOI":"10.1038\/s41598-018-21331-y"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Tan, J., Cho, T.J., Tsai, D.H., Liu, J., Pettibone, J.M., You, R., Hackley, V.A., and Zachariah, M.R. (2018). Surface Modification of Cisplatin-Complexed Gold Nanoparticles and Its Influence on Colloidal Stability, Drug Loading, and Drug Release. Langmuir.","DOI":"10.1021\/acs.langmuir.7b02354"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: A new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1073\/pnas.0737293100","article-title":"New clues for platinum antitumor chemistry: Kinetically controlled metal binding to DNA","volume":"100","author":"Reedijk","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Oliver, T.G., Mercer, K.L., Sayles, L.C., Burke, J.R., Mendus, D., Lovejoy, K.S., Cheng, M.H., Subramanian, A., Mu, D., and Powers, S. (2010). Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer. Genes Dev.","DOI":"10.1101\/gad.1897010"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e47562","DOI":"10.1371\/journal.pone.0047562","article-title":"Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin","volume":"7","author":"Comenge","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Zhao, X., Pan, J., Li, W., Yang, W., Qin, L., and Pan, Y. (2018). Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels. Int. J. Nanomed.","DOI":"10.2147\/IJN.S176928"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2165\/00003495-200565170-00007","article-title":"Docetaxel: A review of its use in metastatic breast cancer","volume":"65","author":"Fenton","year":"2005","journal-title":"Drugs"},{"key":"ref_150","first-page":"S71","article-title":"A new paradigm for the treatment of high-risk prostate cancer: Radiosensitization with docetaxel","volume":"5","author":"Kumar","year":"2003","journal-title":"Rev. Urol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1634\/theoncologist.8-4-361","article-title":"Docetaxel-Based Combined-Modality Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer","volume":"8","author":"Scagliotti","year":"2003","journal-title":"Oncologist"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00000421-199810000-00013","article-title":"Docetaxel in head and neck cancer: A review","volume":"21","author":"Colevas","year":"1998","journal-title":"Am. J. Clin. Oncol. Cancer Clin. Trials"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Fulton, B., and Spencer, C.M. (1996). Docetaxel: A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Efficacy in the Management of Metastatic Breast Cancer. Drugs.","DOI":"10.2165\/00003495-199651060-00011"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Herbst, R.S., and Khuri, F.R. (2003). Mode of action of docetaxel - A basis for combination with novel anticancer agents. Cancer Treat. Rev.","DOI":"10.1016\/S0305-7372(03)00097-5"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Nehm\u00e9, A., Varadarajan, P., Sellakumar, G., Gerhold, M., Niedner, H., Zhang, Q., Lin, X., and Christen, R.D. (2001). Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells. Br. J. Cancer.","DOI":"10.1054\/bjoc.2001.1818"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Loibl, S., Denkert, C., and von Minckwitz, G. (2015). Neoadjuvant treatment of breast cancer-Clinical and research perspective. Breast.","DOI":"10.1016\/j.breast.2015.07.018"},{"key":"ref_157","first-page":"1842","article-title":"Interaction of ionizing radiation with paclitaxel (taxol) and docetaxel (taxotere) in HeLa and SQ20B cells","volume":"56","author":"Hennequin","year":"1996","journal-title":"Cancer Res."},{"key":"ref_158","first-page":"2431","article-title":"Docetaxel enhances tumor radioresponse in vivo","volume":"3","author":"Mason","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Kim, J.A., Aberg, C., Salvati, A., and Dawson, K.A. (2012). Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat. Nanotechnol.","DOI":"10.1038\/nnano.2011.191"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Bannister, A.H., Bromma, K., Sung, W., Monica, M., Cicon, L., Howard, P., Chow, R.L., Schuemann, J., and Chithrani, D.B. (2020). Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy. Br. J. Radiol., 93.","DOI":"10.1259\/bjr.20190742"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Burris, H.A., Moore, M.J., Andersen, J., Green, M.R., Rothenberg, M.L., Modiano, M.R., Cripps, M.C., Portenoy, R.K., Storniolo, A.M., and Tarassoff, P. (1997). Improvements in survival and clinical benefit with gemcitabine as first- line therapy for patients with advanced pancreas cancer: A randomized trial. J. Clin. Oncol.","DOI":"10.1200\/JCO.1997.15.6.2403"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1464-410X.2011.10880.x","article-title":"Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): A systematic review","volume":"109","author":"Shelley","year":"2012","journal-title":"BJU Int."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Kroep, J.R., Giaccone, G., Tolis, C., Voorn, D.A., Loves, W.J.P., Van Groeningen, C.J., Pinedo, H.M., and Peters, G.J. (2000). Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines. Br. J. Cancer.","DOI":"10.1054\/bjoc.2000.1399"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0163-7258(00)00086-3","article-title":"Basis for effective combination cancer chemotherapy with antimetabolites","volume":"87","author":"Peters","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Peters, G.J., Clavel, M., Noordhuis, P., Geyssen, G.J., Laan, A.C., Guastalla, J., Edzes, H.T., and Vermorken, J.B. (2007). Clinical phase I and pharmacology study of gemcitabine (2\u2032, 2\u2032-difluorodeoxycytidine) administered in a two-weekly schedule. J. Chemother.","DOI":"10.1179\/joc.2007.19.2.212"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Huai, Y., Zhang, Y., Xiong, X., Das, S., Bhattacharya, R., and Mukherjee, P. (2019). Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine. Cell Stress.","DOI":"10.15698\/cst2019.08.195"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: The mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Pal, K., Al-Suraih, F., Gonzalez-Rodriguez, R., Dutta, S.K., Wang, E., Kwak, H.S., Caulfield, T.R., Coffer, J.L., and Bhattacharya, S. (2017). Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer. Nanoscale.","DOI":"10.1039\/C7NR03172F"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Loehrer, P.J., Feng, Y., Cardenes, H., Wagner, L., Brell, J.M., Cella, D., Flynn, P., Ramanathan, R.K., Crane, C.H., and Alberts, S.R. (2011). Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial. J. Clin. Oncol.","DOI":"10.1200\/JCO.2011.34.8904"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Davidi, E.S., Dreifuss, T., Motiei, M., Shai, E., Bragilovski, D., Lubimov, L., Kindler, M.J.J., Popovtzer, A., Don, J., and Popovtzer, R. (2018). Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer. Head Neck.","DOI":"10.1117\/12.2289459"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Peng, C., Xu, J., Yu, M., Ning, X., Huang, Y., Du, B., Hernandez, E., Kapur, P., Hsieh, J.T., and Zheng, J. (2019). Tuning the In Vivo Transport of Anticancer Drugs Using Renal-Clearable Gold Nanoparticles. Angew. Chem.-Int. Ed.","DOI":"10.1002\/anie.201903256"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Kalimuthu, K., Lubin, B.C., Bazylevich, A., Gellerman, G., Shpilberg, O., Luboshits, G., and Firer, M.A. (2018). Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells. J. Nanobiotechnol.","DOI":"10.1186\/s12951-018-0362-1"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Alamzadeh, Z., Beik, J., Mirrahimi, M., Shakeri-Zadeh, A., Ebrahimi, F., Komeili, A., Ghalandari, B., Ghaznavi, H., Kamrava, S.K., and Moustakis, C. (2020). Gold nanoparticles promote a multimodal synergistic cancer therapy strategy by co-delivery of thermo-chemo-radio therapy. Eur. J. Pharm. Sci.","DOI":"10.1016\/j.ejps.2020.105235"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Safwat, M.A., Soliman, G.M., Sayed, D., and Attia, M.A. (2016). Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells. Int. J. Pharm.","DOI":"10.1016\/j.ijpharm.2016.09.076"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Fathy, M.M., Mohamed, F.S., Elbialy, N.S., and Elshemey, W.M. (2018). Multifunctional Chitosan-Capped Gold Nanoparticles for enhanced cancer chemo-radiotherapy: An invitro study. Phys. Med.","DOI":"10.1016\/j.ejmp.2018.04.002"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Wilhelm, S., Tavares, A.J., Dai, Q., Ohta, S., Audet, J., Dvorak, H.F., and Chan, W.C.W. (2016). Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater., 1.","DOI":"10.1038\/natrevmats.2016.14"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm2010001","article-title":"Personalized medicine and cancer","volume":"2","author":"Verma","year":"2012","journal-title":"J. Pers. Med."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Krzyszczyk, P., Acevedo, A., Davidoff, E.J., Timmins, L.M., Marrero-Berrios, I., Patel, M., White, C., Lowe, C., Sherba, J.J., and Hartmanshenn, C. (2018). The growing role of precision and personalized medicine for cancer treatment. Technology.","DOI":"10.1142\/S2339547818300020"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Fan, H., Demirci, U., and Chen, P. (2019). Emerging organoid models: Leaping forward in cancer research. J. Hematol. Oncol., 12.","DOI":"10.1186\/s13045-019-0832-4"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ncb3312","article-title":"Organoids as an in vitro model of human development and disease","volume":"18","author":"Fatehullah","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"G257","DOI":"10.1152\/ajpgi.00410.2016","article-title":"CRISPR\/Cas 9 genome editing and its applications in organoids","volume":"312","author":"Driehuis","year":"2017","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Yao, Y., Xu, X., Yang, L., Zhu, J., Wan, J., Shen, L., Xia, F., Fu, G., Deng, Y., and Pan, M. (2020). Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer. Cell Stem Cell.","DOI":"10.1016\/j.stem.2019.10.010"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-1586-1","article-title":"The challenge of developing human 3D organoids into medicines","volume":"11","author":"Vives","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Dossena, M., Piras, R., Cherubini, A., Barilani, M., Dugnani, E., Salanitro, F., Moreth, T., Pampaloni, F., Piemonti, L., and Lazzari, L. (2020). Standardized GMP-compliant scalable production of human pancreas organoids. Stem Cell Res. Ther.","DOI":"10.1186\/s13287-020-1585-2"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Quereda, V., Hou, S., Madoux, F., Scampavia, L., Spicer, T.P., and Duckett, D. (2018). A Cytotoxic Three-Dimensional-Spheroid, High-Throughput Assay Using Patient-Derived Glioma Stem Cells. SLAS Discov.","DOI":"10.1177\/2472555218775055"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Br\u00fcningk, S.C., Rivens, I., Box, C., Oelfke, U., and ter Haar, G. (2020). 3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments. Sci. Rep.","DOI":"10.1038\/s41598-020-58569-4"}],"container-title":["Nanomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-4991\/10\/9\/1671\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:06:57Z","timestamp":1760177217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-4991\/10\/9\/1671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":187,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["nano10091671"],"URL":"https:\/\/doi.org\/10.3390\/nano10091671","relation":{},"ISSN":["2079-4991"],"issn-type":[{"value":"2079-4991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]}}}